Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 20/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4036199 | 0.99 | KIF11 (0.83) | KIF11 | |
| SCHEMBL4037139 | 0.93 | KIF11 (0.74) | KIF11 | |
| Hydrochloric Acid SCHEMBL4045046 | 0.93 | KIF11 (0.73) | KIF11 | |
| SCHEMBL3871453 | 0.92 | KIF11 (1.00) | KIF11 | |
| SCHEMBL3873980 | 0.92 | KIF11 (1.00) | KIF11 | |
| SCHEMBL3872670 | 0.92 | KIF11 (1.00) | KIF11 | |
| SCHEMBL4039867 | 0.91 | KIF11 (0.70) | KIF11 | |
| Hydrochloric Acid SCHEMBL3867081 | 0.91 | KIF11 (0.98) | KIF11 | |
| Hydrochloric Acid SCHEMBL3867077 | 0.90 | KIF11 (0.97) | KIF11 | |
| SCHEMBL5803232 | 0.90 | KIF11 (0.84) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1601673-B1 | FUSED HETEROCYCLES AND USES THEREOF | ASTRAZENECA AB (SE) | 2009-06-10 | — | — | EP | claimed |
| EP-1601673-B1 | FUSED HETEROCYCLES AND USES THEREOF | ASTRAZENECA AB (SE) | 2009-06-10 | — | — | EP | disclosed |
| EP-1628981-A2 | BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES | Bristol-Myers Squibb Company (US) | 2006-03-01 | — | — | EP | disclosed |
| WO-2004106492-A2 | BICYCLICPYRIMIDONES AND THEIR USE TO TREAT DISEASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-12-09 | — | — | WO | disclosed |